CCR3 antagonist 1

CAS No. 879399-82-3

CCR3 antagonist 1( —— )

Catalog No. M32754 CAS No. 879399-82-3

CCR3 antagonist 1 is a potent CCR3 antagonist used in researching inflammatory and immunologic diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 141 In Stock
5MG 188 In Stock
10MG 306 In Stock
25MG 473 In Stock
50MG 635 In Stock
100MG 837 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CCR3 antagonist 1
  • Note
    Research use only, not for human use.
  • Brief Description
    CCR3 antagonist 1 is a potent CCR3 antagonist used in researching inflammatory and immunologic diseases.
  • Description
    CCR3 antagonist 1 is a potent antagonist of CCR3, used for the research of immunologic and inflammatory diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    CCR
  • Recptor
    CCR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    879399-82-3
  • Formula Weight
    490.42
  • Molecular Formula
    C19H21Cl2N3O4S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (254.88 mM; Ultrasonic )
  • SMILES
    C(N1C[C@H](CNC(CSC2=NC(CC(O)=O)=CS2)=O)OCC1)C3=CC(Cl)=C(Cl)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. MORPHOLINE COMPOUND. WO 2006028284 A1
molnova catalog
related products
  • CCR2 antagonist 4

    CCR2 antagonist 4 is a potent and specific antagonist of CCR2(IC50s of 180 nM), and potently inhibits MCP-1-induced chemotaxis(IC50 of 24 nM).

  • Plozalizumab

    Plozalizumab (MLN-1202) is a humanized, selective, and potent anti-CCR2 antibody with antitumor activity, used in the study of malignant melanoma.

  • VER-49009 (b)

    VER-49009 is an effective HSP90 inhibitor(IC50 =25 nM, Kd=78 nM).